Please select a region
Manage Consent Preferences
Cookie Details
Strictly Functional Cookie
Analytics Cookie
Targeting Cookie
Back
Analytics Cookies
x
Cookies List
Our site is undergoing a scheduled maintenance from 30th December 2020 to 3rd January 2021 and some functionalities will not be available at this time
Loading your cart..
-
Products
Products
-
Services
Services
-
-
Challenges
Challenges
-
Reducing Total Cost of Ownership
Solving the Challenge of High pH Injectable Drug ProductsClick HerePackaging Solutions for Sensitive Molecules
Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
-
-
Support
Support
-
Regulatory SupportWest Regulatory Affairs provides a single point of contact to assist with global registration strategies for all West products and processes.Regulatory SupportKnowledge CenterThe West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.Knowledge Center
-
Services
Challenges

Solving the Challenge of High pH Injectable Drug Products
Click Here

Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
Support
Regulatory Support
West Regulatory Affairs provides a single point of contact to assist with global registration strategies for all West products and processes.
Regulatory Support
Knowledge Center
The West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.
Knowledge Center
- Home
Blog
The West Blog
Latest Post
January 21, 2021
West's Envision™ Verification System – Risk Mitigation for Quality of Drug Product
One factor of parenteral drug product quality is the container closure integrity (CCI) of the primary packaging system. The interaction between the sealing surface of the elastomeric component and the vial is vital to ensure stability of the drug product over the shelf life. Therefore, defects found on the elastomeric component can increase the risk of failure or end-of-the-line rejects.
Categories
Search the Blog
Archive
Load more
Loading...
Previous Posts

July 10, 2020
Mitigating Risk in Pharmaceutical Manufacturing with Visually-Inspected Components

Olga Laskina, Ph.D.
Sr. Technical Account Specialist, NA

June 26, 2018
Inspecting Elastomer Components: Can You Spot a Defect?

Bill Matakas
Sr. Director, Product Management & Marketing Operations